NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
66 hedge funds and large institutions have $15.3M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
90% less call options, than puts
Call options by funds: $40K | Put options by funds: $397K
Holders
66
Holding in Top 10
–
Calls
$40K
Puts
$397K
Top Buyers
| 1 | +$624K | |
| 2 | +$557K | |
| 3 | +$146K | |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$118K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$100K |
Top Sellers
| 1 | -$1.34M | |
| 2 | -$613K | |
| 3 | -$476K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$428K |
| 5 |
DBG
De Burlo Group
Boston,
Massachusetts
|
-$359K |